Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

807
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

28
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
28
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

38
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Histological Gastritis in a Community Population and Association with Epigastric Pain.

Digestive diseases and sciences·2023
Same author

Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.

Alimentary pharmacology & therapeutics·2018
Same author

Multiple functional gastrointestinal disorders linked to gastroesophageal reflux and somatization: A population-based study.

Neurogastroenterology and motility·2017
Same author

Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.

Mucosal immunology·2017
Same author

Rumination syndrome: pathophysiology, diagnosis, and treatment.

Neurogastroenterology and motility·2016
Same author

Letter: evidence of gut-to-brain and brain-to-gut pathways in the pathogenesis of functional gastrointestinal disorders - 'first-ever' incidence would be needed to draw conclusions. Authors' reply.

Alimentary pharmacology & therapeutics·2016

Related Experiment Video

Updated: May 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K

Dyspepsia: current understanding and management

L Agréus1, N J Talley

  • 1Department of Family Medicine, Uppsala University, Akademiska Sjukhuset, Sweden.

Annual Review of Medicine
|March 24, 1998
PubMed
Summary

Dyspepsia affects many adults, with treatment options varying by cause. For H. pylori positive patients, eradication therapy is effective, while prokinetics benefit non-ulcer dyspepsia.

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Dyspepsia, characterized by upper abdominal pain, affects a significant portion of the adult population.
  • Key causes include functional dyspepsia, peptic ulcer disease, and gastroesophageal reflux disease.
  • Symptom-based classification of dyspepsia has limited clinical utility in identifying underlying causes.

Purpose of the Study:

  • To review the diagnostic approaches and treatment strategies for dyspepsia.
  • To evaluate the role of Helicobacter pylori infection in dyspepsia management.
  • To assess the efficacy of different therapeutic options for non-ulcer dyspepsia.

Main Methods:

  • Review of current medical literature and clinical guidelines.
  • Analysis of diagnostic test yields, including upper endoscopy, ultrasound, and blood tests.

More Related Videos

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.8K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Related Experiment Videos

Last Updated: May 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

6.3K
Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.8K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K
  • Evaluation of treatment outcomes for empiric H. pylori therapy and pharmacologic interventions.

    • Main Results:

    • Upper endoscopy is the gold standard for diagnosing dyspepsia causes; other tests have limited value.
    • Empiric anti-H. pylori therapy is a cost-effective option for infected, uninvestigated dyspepsia patients.
    • Prokinetic agents demonstrate superior efficacy compared to placebo in documented non-ulcer dyspepsia.

    Conclusions:

    • Dyspepsia management requires careful consideration of potential causes and diagnostic findings.
    • Helicobacter pylori eradication is a key strategy for relevant dyspeptic subgroups.
    • Treatment choice for non-ulcer dyspepsia should prioritize prokinetic therapy over less certain options.